![Nuclear factor‐kappa β as a therapeutic target for Alzheimer's disease - Jha - 2019 - Journal of Neurochemistry - Wiley Online Library Nuclear factor‐kappa β as a therapeutic target for Alzheimer's disease - Jha - 2019 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c1671fb6-9b23-4ea0-9e89-edfb4bb3f7c5/jnc14687-fig-0007-m.png)
Nuclear factor‐kappa β as a therapeutic target for Alzheimer's disease - Jha - 2019 - Journal of Neurochemistry - Wiley Online Library
![Cells | Free Full-Text | Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases | HTML Cells | Free Full-Text | Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases | HTML](https://www.mdpi.com/cells/cells-09-01627/article_deploy/html/images/cells-09-01627-g003.png)
Cells | Free Full-Text | Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases | HTML
![NF-κB inducers and its target genes. A, NF-κB is activated by various... | Download Scientific Diagram NF-κB inducers and its target genes. A, NF-κB is activated by various... | Download Scientific Diagram](https://www.researchgate.net/publication/6457819/figure/fig1/AS:601621549576192@1520449163016/Fig-1-NF-kB-inducers-and-its-target-genes-A-NF-kB-is-activated-by-various-inducers.png)
NF-κB inducers and its target genes. A, NF-κB is activated by various... | Download Scientific Diagram
![The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019) The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)](https://erc.bioscientifica.com/view/journals/erc/26/6/images/full-ERC-19-0087fig3.jpeg)
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
![Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-020-00312-6/MediaObjects/41392_2020_312_Fig1_HTML.png)
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy
![Inflammatory regulatory network mediated by the joint action of NF-kB, STAT3, and AP-1 factors is involved in many human cancers | PNAS Inflammatory regulatory network mediated by the joint action of NF-kB, STAT3, and AP-1 factors is involved in many human cancers | PNAS](https://www.pnas.org/cms/10.1073/pnas.1821068116/asset/387b03fa-3795-4344-b29a-cc5c88c04939/assets/graphic/pnas.1821068116fig03.jpeg)
Inflammatory regulatory network mediated by the joint action of NF-kB, STAT3, and AP-1 factors is involved in many human cancers | PNAS
![Frontiers | The NF-κB Signaling Pathway, the Microbiota, and Gastrointestinal Tumorigenesis: Recent Advances Frontiers | The NF-κB Signaling Pathway, the Microbiota, and Gastrointestinal Tumorigenesis: Recent Advances](https://www.frontiersin.org/files/Articles/544407/fimmu-11-01387-HTML/image_m/fimmu-11-01387-g001.jpg)
Frontiers | The NF-κB Signaling Pathway, the Microbiota, and Gastrointestinal Tumorigenesis: Recent Advances
![Inflammatory regulatory network mediated by the joint action of NF-kB, STAT3, and AP-1 factors is involved in many human cancers | PNAS Inflammatory regulatory network mediated by the joint action of NF-kB, STAT3, and AP-1 factors is involved in many human cancers | PNAS](https://www.pnas.org/cms/10.1073/pnas.1821068116/asset/ad081b30-71fa-4826-972e-1c42637f0651/assets/graphic/pnas.1821068116fig02.jpeg)